Press "Enter" to skip to content

Liquid Biopsy Market Size, Share | Industry Trend Report

Global Liquid Biopsy Market was valued at USD 1.32 billion in 2021 and is expected to reach USD 4.79 billion by the year 2028, at a CAGR of 20.2%.

A liquid biopsy is a simple and non-invasive alternative to surgical biopsies that allows doctors to learn about tumors from a simple blood sample. In 1994, scientists advanced to the point where they could detect specific mutations in cfDNA. Dennis Lo discovered fetal cfDNA in the blood in 1997, and Veridex released the first commercially available liquid biopsy assay, the CELL SEARCH CTC test, in 2000. The FDA approved the first liquid biopsy test, the Cobas EGFR Mutation Test, as a cfDNA test for the EGFR gene mutation in lung cancer patients’ blood in June 2016.

Read More: Biopsy Market

We offer a sample report that includes the following:

  1. Overview, Industry Analysis, and Introduction are all included in the 2022 update report.
  2. The package contains the COVID-19 Pandemic Impact Analysis.
  3. Provide chapter-by-chapter guidance regarding the Request
  4. An Updated Regional Analysis Using a Graphical Representation Of Size, Share, and Trends For The Year 2022
  5. Tables & Figures have been updated
  6. The latest version of this report includes the Top Market Participants, their Business Strategies, SWOT Analysis, and Historical Growth.
  7. Facts, Factors, Research Methodology

(Please note that this report includes the COVID-19 impact study.)

Get Access to Sample Pages

Key Prominent Players In The Liquid Biopsy Market:

  1. Hoffmann-La Roche Ltd. (Switzerland), Myriad Genetics Inc. (US), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific Inc. (the US), Guardant Health Inc. (the US), BIOCEPT Inc. (the US), Illumina Inc. (the US), Angle plc (UK), Oncimmune(UK), Lucence health Inc. (US), FreenomeHoldings Inc. (US) and Other Major Players.

Market segmentation

The Liquid Biopsy market is segmented by type and application. Growth between segments over the period 2022-2028 provides accurate calculations and forecasts of revenue by type and application in terms of volume and value. This analysis can help you expand your business by targeting eligible niches.

Liquid Biopsy Market Segment by Types, Estimates, and Forecast by 2028

Lung, Breast, Liver, Others

Liquid Biopsy Market Segment by Applications, Estimates, and Forecast by 2028

Hospitals, Laboratories, Government Research Centre

Regional Analysis for COVID-19 Outbreak-Global Liquid Biopsy Market:

  • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC)
  • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
  • North America (U.S., Canada, and Mexico)
  • South America (Brazil, Chile, Argentina, Rest of South America)
  • MEA (Saudi Arabia, UAE, South Africa)

For inquiry, click here@:

The report contains insights about the following:

  1. Market Penetration: provides comprehensive information on the market, including the key players
  2. Market Development: Provides detailed information about profitable emerging markets and analyses penetration across the mature markets
  3. Market Diversification: Information about new product launches and untapped geographies is provided. Recent developments.
  4. Competitive Assessment and Intelligence: This comprehensive report analyzes market shares, strategies, and products, as well as certifications, regulatory approvals, patent landscapes, and manufacturing capabilities for the top players.
  5. Product Development & Innovation: Provides smart insights about future technologies, R&D activities as well as breakthrough product developments

Purchase This Premium Report Now @

The report answers such questions as:

  1. What is the market size for Liquid Biopsy and its forecast?
  2. What are the limiting factors and the impact of COVID-19 in shaping the Global Liquid Biopsy Market?
  3. Which products/segments/applications/areas to invest in over the Global Liquid Biopsy Market forecast period?
  4. What is the Global Liquid Biopsy Market’s strategic competitive window for new opportunities?
  5. What technology trends are there in the Global Liquid Biopsy Market?
  6. What is the market size of the most prominent vendors in the Global Liquid Biopsy Marketplace?
  7. What strategic moves and methods are appropriate for entry into the Global Liquid Biopsy Market?

(NOTE:Avail the Thanksgiving and Black Friday 2022 Discount offers*; We are offering FLAT 50% Discount* on all our reports. This offer is valid till 15th December 2022.)







About Us:

Introspective Market Research ( is a visionary research consulting firm dedicated to assist our clients grow and have a successful impact on the market. Our team at IMR is ready to assist our clients flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, specialized in using big data and advanced analytics to show the bigger picture of the market trends. We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyse extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.

Contact Us:

Mike Cooper

Business Development Manager

3001 S King Drive, Chicago, Illinois,

U.S. A 60616

Contact No: USA: +1 (773)-382-1047 / IND: +91-81-8009-6367


Be First to Comment

Leave a Reply

Your email address will not be published.